Comments
U.S. approves Spectrum Pharma's purchase of Allos
01.09.2012. | WASHINGTON (Reuters) - U.S. antitrust officials have approved Spectrum Pharmaceuticals' purchase of cancer drugmaker Allos Therapeutics, a $206 million deal aimed at giving Spectrum access to the Allos anti-cancer drug Folotyn....
